Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes

Levels of Soluble Advanced Glycation End Product-Receptors and Other Soluble Serum Markers as Indicators of Diabetic Neuropathy in the Foot

(2016) Hala O. El-Mesallamy et al.   JOURNAL OF INVESTIGATIVE MEDICINE

Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study

(2012) M. J. Noordzij et al.   DIABETIC MEDICINE

Association between sRAGE, esRAGE levels and vascular inflammation: Analysis with 18F-fluorodeoxyglucose positron emission tomography

(2011) Sae Jeong Yang et al.   ATHEROSCLEROSIS

Loss of RAGE Defense: A Cause of Charcot Neuroarthropathy?

(2011) K. A. Witzke et al.   DIABETES CARE

Evaluation of Nonenzymatic Posttranslational Modification-Derived Products as Biomarkers of Molecular Aging of Proteins

(2010) S. Jaisson et al.   CLINICAL CHEMISTRY

Advanced glycation end-products and the kidney

(2010) Martin Busch et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION